Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have uncovered a previously unknown mechanism that helps cancer cells evade detection by the body’s immune system. The finding could pave the way for the development of more effective cancer immunotherapies.

Published in Science Immunology, the study identifies the RNA helicase DDX6 as a previously unrecognized “hidden switch” that prevents the immune system from recognizing cancer cells. Targeting DDX6 could make tumors more visible to the immune system, improving existing or new immunotherapies.